The diagnostics advisory committee considered evidence on FibroScan for assessing liver fibrosis and cirrhosis from several sources, including an external assessment report and an overview of that ...
This article is brought to you by Our Lady of the Angels. An innovative non-invasive technology at Our Lady of the Angels is helping doctors better detect liver problems, leading to earlier treatment ...
The National Institute for Health and Health and Care Excellence (NICE) has recommended FibroScan, a non-invasive hepatic ultrasound scan, as an option for assessing liver damage from fibrosis and ...
As waistlines grow, more people’s weight is on the rise, and so is fatty liver disease. It’s a serious medical condition that increases the risk of liver cancer and cirrhosis, but now doctors can ...
PARIS & WALTHAM, Mass.--(BUSINESS WIRE)--Echosens, a high-technology company offering the FibroScan family of products, announces today that the National Institute for Health and Care Excellence (NICE ...
Please provide your email address to receive an email when new articles are posted on . PHILADELPHIA — FibroScan screening for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis could ...
WALTHAM, Mass. & PARIS--(BUSINESS WIRE)--Echosens, a high-technology company offering the FibroScan family of products, today announces the publication of the “FibroScan-AST (FAST) Score For The ...
This milestone opens a path for FibroScan ® to ultimately replace liver biopsy for patient enrollment and treatment response assessment in MASH drug development WESTBOROUGH, Mass., Sept. 8, 2025 ...
Just a few years ago, Grand Junction gastroenterologist Dr. William Shields was administering a lot of biopsies to diagnose the level of scarring in a patient's liver. The process involves a needle ...
SCOTT DEPOT, W.Va. — Early detection and intervention are keys to preventing the progression of many diseases, including liver disease, according to a news release from Marshall Health, which now ...
The study period for sample acquisition was from September 2005 to June 2008. The Serum bank of the J.W. Goethe-University Hospital was checked for serum of patients with chronic liver disease, who ...
It is expected that additional FibroScan devices may be required in primary or community care settings to implement the guidance. The recommendations will also require a change to the setting that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results